GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:0030334	regulation of cell migration	1E-7	6.54E-4	2.33	679	50	175	30	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, DPP4  -  dipeptidyl-peptidase 4, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, ADORA3  -  adenosine a3 receptor, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, LAMB1  -  laminin, beta 1]
GO:0006928	movement of cell or subcellular component	1.51E-7	4.93E-4	1.86	679	100	175	48	[SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DST  -  dystonin, NEO1  -  neogenin 1, DOCK4  -  dedicator of cytokinesis 4, KIF5C  -  kinesin family member 5c, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, DPP4  -  dipeptidyl-peptidase 4, ASTN2  -  astrotactin 2, NRP2  -  neuropilin 2, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, NRXN3  -  neurexin 3, GPC4  -  glypican 4, DPYSL2  -  dihydropyrimidinase-like 2, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, ADCY3  -  adenylate cyclase 3, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, KIF13B  -  kinesin family member 13b, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, MYO5C  -  myosin vc, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, MYO5A  -  myosin va (heavy chain 12, myoxin), MYO1E  -  myosin ie, FAT1  -  fat atypical cadherin 1, NRCAM  -  neuronal cell adhesion molecule, LAMB1  -  laminin, beta 1]
GO:2000145	regulation of cell motility	1.9E-7	4.13E-4	2.28	679	51	175	30	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, DPP4  -  dipeptidyl-peptidase 4, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, ADORA3  -  adenosine a3 receptor, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, LAMB1  -  laminin, beta 1]
GO:0010595	positive regulation of endothelial cell migration	2.62E-7	4.27E-4	3.88	679	11	175	11	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, MET  -  met proto-oncogene, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma]
GO:0016477	cell migration	4.47E-7	5.82E-4	2.19	679	55	175	31	[SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DOCK4  -  dedicator of cytokinesis 4, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, ASTN2  -  astrotactin 2, DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DISC1  -  disrupted in schizophrenia 1, FAT1  -  fat atypical cadherin 1, NRCAM  -  neuronal cell adhesion molecule, LAMB1  -  laminin, beta 1]
GO:0010594	regulation of endothelial cell migration	9.91E-7	1.08E-3	3.36	679	15	175	13	[MET  -  met proto-oncogene, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, VASH1  -  vasohibin 1, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61)]
GO:0048870	cell motility	1.1E-6	1.03E-3	2.07	679	62	175	33	[DST  -  dystonin, SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DOCK4  -  dedicator of cytokinesis 4, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, ASTN2  -  astrotactin 2, DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ADCY3  -  adenylate cyclase 3, DOCK8  -  dedicator of cytokinesis 8, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DISC1  -  disrupted in schizophrenia 1, FAT1  -  fat atypical cadherin 1, LAMB1  -  laminin, beta 1, NRCAM  -  neuronal cell adhesion molecule]
GO:0040012	regulation of locomotion	1.88E-6	1.53E-3	2.12	679	55	175	30	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, ADORA3  -  adenosine a3 receptor, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, LAMB1  -  laminin, beta 1]
GO:0051270	regulation of cellular component movement	2.23E-6	1.61E-3	2.07	679	58	175	31	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, ADORA3  -  adenosine a3 receptor, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK2  -  ankyrin 2, neuronal, LAMB1  -  laminin, beta 1]
GO:0030155	regulation of cell adhesion	3.23E-6	2.1E-3	2.26	679	43	175	25	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, BST1  -  bone marrow stromal cell antigen 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), DOCK8  -  dedicator of cytokinesis 8, ZBTB16  -  zinc finger and btb domain containing 16, HLA-A  -  major histocompatibility complex, class i, a, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, VSIG4  -  v-set and immunoglobulin domain containing 4, PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK3  -  ankyrin 3, node of ranvier (ankyrin g)]
GO:0040011	locomotion	3.51E-6	2.08E-3	1.94	679	70	175	35	[DST  -  dystonin, SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DOCK4  -  dedicator of cytokinesis 4, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, ASTN2  -  astrotactin 2, DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ADCY3  -  adenylate cyclase 3, DOCK8  -  dedicator of cytokinesis 8, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, MET  -  met proto-oncogene, EXT1  -  exostosin glycosyltransferase 1, PLXNA4  -  plexin a4, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, PLAUR  -  plasminogen activator, urokinase receptor, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DISC1  -  disrupted in schizophrenia 1, FAT1  -  fat atypical cadherin 1, NRCAM  -  neuronal cell adhesion molecule, LAMB1  -  laminin, beta 1]
GO:0030335	positive regulation of cell migration	4.74E-6	2.57E-3	2.54	679	29	175	19	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, LAMB1  -  laminin, beta 1]
GO:2000147	positive regulation of cell motility	4.74E-6	2.38E-3	2.54	679	29	175	19	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, LAMB1  -  laminin, beta 1]
GO:0040017	positive regulation of locomotion	1E-5	4.66E-3	2.46	679	30	175	19	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, LAMB1  -  laminin, beta 1]
GO:0051272	positive regulation of cellular component movement	1E-5	4.35E-3	2.46	679	30	175	19	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, LAMB1  -  laminin, beta 1]
GO:0051239	regulation of multicellular organismal process	1.04E-5	4.25E-3	1.43	679	212	175	78	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, DOCK4  -  dedicator of cytokinesis 4, ADRB2  -  adrenoceptor beta 2, surface, EPPK1  -  epiplakin 1, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, NRP2  -  neuropilin 2, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, NPAS2  -  neuronal pas domain protein 2, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, KCNMA1  -  potassium large conductance calcium-activated channel, subfamily m, alpha member 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ZBTB16  -  zinc finger and btb domain containing 16, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, HLA-A  -  major histocompatibility complex, class i, a, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, HLA-B  -  major histocompatibility complex, class i, b, CD38  -  cd38 molecule, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA2D3  -  calcium channel, voltage-dependent, alpha 2/delta subunit 3, KIF13B  -  kinesin family member 13b, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, PLAUR  -  plasminogen activator, urokinase receptor, SDC2  -  syndecan 2, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, DISC1  -  disrupted in schizophrenia 1, CADM1  -  cell adhesion molecule 1, TSHZ3  -  teashirt zinc finger homeobox 3, IL1R2  -  interleukin 1 receptor, type ii, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, PRICKLE1  -  prickle homolog 1 (drosophila), NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SASH1  -  sam and sh3 domain containing 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, RNF135  -  ring finger protein 135, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, VSIG4  -  v-set and immunoglobulin domain containing 4, ADORA3  -  adenosine a3 receptor, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, TCF4  -  transcription factor 4, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, NEGR1  -  neuronal growth regulator 1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK2  -  ankyrin 2, neuronal, NRCAM  -  neuronal cell adhesion molecule]
GO:0010632	regulation of epithelial cell migration	1.08E-5	4.14E-3	2.77	679	21	175	15	[MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, EPPK1  -  epiplakin 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, VASH1  -  vasohibin 1, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61)]
GO:0010634	positive regulation of epithelial cell migration	1.36E-5	4.93E-3	3.10	679	15	175	12	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK1  -  dedicator of cytokinesis 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma]
GO:0006935	chemotaxis	1.36E-5	4.67E-3	3.10	679	15	175	12	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, DPP4  -  dipeptidyl-peptidase 4, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, NRP2  -  neuropilin 2, PLAUR  -  plasminogen activator, urokinase receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, PLXNA4  -  plexin a4]
GO:0002376	immune system process	1.81E-5	5.89E-3	1.84	679	74	175	35	[MUC12  -  mucin 12, cell surface associated, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, HLA-G  -  major histocompatibility complex, class i, g, ABCA13  -  atp-binding cassette, sub-family a (abc1), member 13, IL1R2  -  interleukin 1 receptor, type ii, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, PXDN  -  peroxidasin homolog (drosophila), BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, WDFY4  -  wdfy family member 4, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, HLA-A  -  major histocompatibility complex, class i, a, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, CD38  -  cd38 molecule, HLA-B  -  major histocompatibility complex, class i, b, DOCK1  -  dedicator of cytokinesis 1, EXT1  -  exostosin glycosyltransferase 1, KIF13B  -  kinesin family member 13b, VSIG4  -  v-set and immunoglobulin domain containing 4, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, PLAUR  -  plasminogen activator, urokinase receptor, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTPRB  -  protein tyrosine phosphatase, receptor type, b, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0022603	regulation of anatomical structure morphogenesis	2.73E-5	8.47E-3	1.76	679	84	175	38	[HLA-G  -  major histocompatibility complex, class i, g, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, SYT17  -  synaptotagmin xvii, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PRICKLE1  -  prickle homolog 1 (drosophila), SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, EPHB2  -  eph receptor b2, DOCK1  -  dedicator of cytokinesis 1, KIF13B  -  kinesin family member 13b, PLXNA4  -  plexin a4, SDC2  -  syndecan 2, VASH1  -  vasohibin 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, NRCAM  -  neuronal cell adhesion molecule]
GO:1904018	positive regulation of vasculature development	3.34E-5	9.87E-3	3.49	679	10	175	9	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0045766	positive regulation of angiogenesis	3.34E-5	9.45E-3	3.49	679	10	175	9	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:0002684	positive regulation of immune system process	3.7E-5	1E-2	1.98	679	53	175	27	[CADM1  -  cell adhesion molecule 1, MUC12  -  mucin 12, cell surface associated, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, DOCK8  -  dedicator of cytokinesis 8, ZBTB16  -  zinc finger and btb domain containing 16, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, CD38  -  cd38 molecule, DOCK1  -  dedicator of cytokinesis 1, VSIG4  -  v-set and immunoglobulin domain containing 4, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0042330	taxis	4.22E-5	1.1E-2	2.91	679	16	175	12	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, DPP4  -  dipeptidyl-peptidase 4, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, NRP2  -  neuropilin 2, PLAUR  -  plasminogen activator, urokinase receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, PLXNA4  -  plexin a4]
GO:0045595	regulation of cell differentiation	5.78E-5	1.45E-2	1.56	679	124	175	50	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, CD38  -  cd38 molecule, HLA-B  -  major histocompatibility complex, class i, b, DIXDC1  -  dix domain containing 1, AR  -  androgen receptor, KIF13B  -  kinesin family member 13b, MSR1  -  macrophage scavenger receptor 1, SDC2  -  syndecan 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, DISC1  -  disrupted in schizophrenia 1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, ST7  -  suppression of tumorigenicity 7, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, TCF4  -  transcription factor 4, ANXA1  -  annexin a1, NEGR1  -  neuronal growth regulator 1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0032879	regulation of localization	7.96E-5	1.92E-2	1.43	679	179	175	66	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, DOCK4  -  dedicator of cytokinesis 4, ADRB2  -  adrenoceptor beta 2, surface, SYT17  -  synaptotagmin xvii, EPPK1  -  epiplakin 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, ASTN2  -  astrotactin 2, DPP4  -  dipeptidyl-peptidase 4, NRP2  -  neuropilin 2, BST1  -  bone marrow stromal cell antigen 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), DPYSL3  -  dihydropyrimidinase-like 3, KCNMA1  -  potassium large conductance calcium-activated channel, subfamily m, alpha member 1, DOCK8  -  dedicator of cytokinesis 8, APBB1  -  amyloid beta (a4) precursor protein-binding, family b, member 1 (fe65), CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, STXBP1  -  syntaxin binding protein 1, CD38  -  cd38 molecule, CADPS2  -  ca++-dependent secretion activator 2, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, AR  -  androgen receptor, CACNA2D3  -  calcium channel, voltage-dependent, alpha 2/delta subunit 3, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, MSR1  -  macrophage scavenger receptor 1, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, RASSF5  -  ras association (ralgds/af-6) domain family member 5, ICA1  -  islet cell autoantigen 1, 69kda, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADCY5  -  adenylate cyclase 5, RIMS3  -  regulating synaptic membrane exocytosis 3, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), TBC1D5  -  tbc1 domain family, member 5, ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, KCNJ15  -  potassium inwardly-rectifying channel, subfamily j, member 15, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ADORA3  -  adenosine a3 receptor, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK2  -  ankyrin 2, neuronal, ANK3  -  ankyrin 3, node of ranvier (ankyrin g), LAMB1  -  laminin, beta 1]
GO:0045765	regulation of angiogenesis	1.11E-4	2.59E-2	2.74	679	17	175	12	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, VASH1  -  vasohibin 1, HLA-G  -  major histocompatibility complex, class i, g, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
GO:1901342	regulation of vasculature development	1.11E-4	2.5E-2	2.74	679	17	175	12	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, VASH1  -  vasohibin 1, HLA-G  -  major histocompatibility complex, class i, g, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
GO:0050900	leukocyte migration	1.43E-4	3.1E-2	3.17	679	11	175	9	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, ANXA1  -  annexin a1, EXT1  -  exostosin glycosyltransferase 1, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK8  -  dedicator of cytokinesis 8, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma]
GO:0048583	regulation of response to stimulus	1.72E-4	3.61E-2	1.35	679	218	175	76	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, ADRB2  -  adrenoceptor beta 2, surface, EPPK1  -  epiplakin 1, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, BST1  -  bone marrow stromal cell antigen 1, NPAS2  -  neuronal pas domain protein 2, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), MAOA  -  monoamine oxidase a, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, HLA-A  -  major histocompatibility complex, class i, a, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, STXBP1  -  syntaxin binding protein 1, DIXDC1  -  dix domain containing 1, HLA-B  -  major histocompatibility complex, class i, b, CD38  -  cd38 molecule, NR3C2  -  nuclear receptor subfamily 3, group c, member 2, AR  -  androgen receptor, SRGAP3  -  slit-robo rho gtpase activating protein 3, ARHGAP32  -  rho gtpase activating protein 32, PLAUR  -  plasminogen activator, urokinase receptor, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, VASH1  -  vasohibin 1, AUTS2  -  autism susceptibility candidate 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, DISC1  -  disrupted in schizophrenia 1, CGNL1  -  cingulin-like 1, WWOX  -  ww domain containing oxidoreductase, MUC12  -  mucin 12, cell surface associated, CADM1  -  cell adhesion molecule 1, NEO1  -  neogenin 1, IL1R2  -  interleukin 1 receptor, type ii, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, ARHGEF10  -  rho guanine nucleotide exchange factor (gef) 10, KANK1  -  kn motif and ankyrin repeat domains 1, PXDN  -  peroxidasin homolog (drosophila), PRICKLE1  -  prickle homolog 1 (drosophila), NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ADCY5  -  adenylate cyclase 5, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, PTK7  -  protein tyrosine kinase 7, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), VSIG4  -  v-set and immunoglobulin domain containing 4, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, PSD3  -  pleckstrin and sec7 domain containing 3, ARHGEF9  -  cdc42 guanine nucleotide exchange factor (gef) 9]
GO:0050793	regulation of developmental process	2.01E-4	4.1E-2	1.43	679	166	175	61	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, ADRB2  -  adrenoceptor beta 2, surface, SYT17  -  synaptotagmin xvii, EPPK1  -  epiplakin 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, CD38  -  cd38 molecule, HLA-B  -  major histocompatibility complex, class i, b, DIXDC1  -  dix domain containing 1, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, KIF13B  -  kinesin family member 13b, MSR1  -  macrophage scavenger receptor 1, SDC2  -  syndecan 2, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, DISC1  -  disrupted in schizophrenia 1, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SASH1  -  sam and sh3 domain containing 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, ST7  -  suppression of tumorigenicity 7, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, NEGR1  -  neuronal growth regulator 1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0045785	positive regulation of cell adhesion	2.34E-4	4.61E-2	2.33	679	25	175	15	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-G  -  major histocompatibility complex, class i, g, DOCK1  -  dedicator of cytokinesis 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, PLAUR  -  plasminogen activator, urokinase receptor, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK3  -  ankyrin 3, node of ranvier (ankyrin g), DOCK8  -  dedicator of cytokinesis 8, ZBTB16  -  zinc finger and btb domain containing 16]
GO:0060326	cell chemotaxis	2.75E-4	5.26E-2	3.88	679	6	175	6	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma]
GO:0051241	negative regulation of multicellular organismal process	2.92E-4	5.44E-2	1.72	679	70	175	31	[HLA-G  -  major histocompatibility complex, class i, g, DOCK4  -  dedicator of cytokinesis 4, IL1R2  -  interleukin 1 receptor, type ii, ADRB2  -  adrenoceptor beta 2, surface, EPPK1  -  epiplakin 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PBX1  -  pre-b-cell leukemia homeobox 1, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, KCNMA1  -  potassium large conductance calcium-activated channel, subfamily m, alpha member 1, RNF135  -  ring finger protein 135, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, DIXDC1  -  dix domain containing 1, CD38  -  cd38 molecule, EPHB2  -  eph receptor b2, VSIG4  -  v-set and immunoglobulin domain containing 4, PLAUR  -  plasminogen activator, urokinase receptor, VASH1  -  vasohibin 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0002696	positive regulation of leukocyte activation	3.12E-4	5.65E-2	2.36	679	23	175	14	[HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, CD38  -  cd38 molecule, HLA-G  -  major histocompatibility complex, class i, g, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, DOCK8  -  dedicator of cytokinesis 8, ZBTB16  -  zinc finger and btb domain containing 16]
GO:0050867	positive regulation of cell activation	3.12E-4	5.49E-2	2.36	679	23	175	14	[HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, CD38  -  cd38 molecule, HLA-G  -  major histocompatibility complex, class i, g, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, DOCK8  -  dedicator of cytokinesis 8, ZBTB16  -  zinc finger and btb domain containing 16]
GO:0097485	neuron projection guidance	3.12E-4	5.35E-2	2.36	679	23	175	14	[TRIO  -  trio rho guanine nucleotide exchange factor, NEO1  -  neogenin 1, EPHB2  -  eph receptor b2, KIF5C  -  kinesin family member 5c, EXT1  -  exostosin glycosyltransferase 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, NRXN3  -  neurexin 3, PRKCA  -  protein kinase c, alpha, DPYSL2  -  dihydropyrimidinase-like 2, NRCAM  -  neuronal cell adhesion molecule, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0007411	axon guidance	3.12E-4	5.21E-2	2.36	679	23	175	14	[TRIO  -  trio rho guanine nucleotide exchange factor, NEO1  -  neogenin 1, EPHB2  -  eph receptor b2, KIF5C  -  kinesin family member 5c, EXT1  -  exostosin glycosyltransferase 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, NRXN3  -  neurexin 3, PRKCA  -  protein kinase c, alpha, DPYSL2  -  dihydropyrimidinase-like 2, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, NRCAM  -  neuronal cell adhesion molecule]
GO:0001817	regulation of cytokine production	3.38E-4	5.51E-2	2.05	679	36	175	19	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, IL1R2  -  interleukin 1 receptor, type ii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, VSIG4  -  v-set and immunoglobulin domain containing 4, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTPRC  -  protein tyrosine phosphatase, receptor type, c, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, RNF135  -  ring finger protein 135]
GO:0045321	leukocyte activation	3.38E-4	5.37E-2	2.05	679	36	175	19	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-B  -  major histocompatibility complex, class i, b, ABCA13  -  atp-binding cassette, sub-family a (abc1), member 13, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, KIF13B  -  kinesin family member 13b, DPP4  -  dipeptidyl-peptidase 4, PLAUR  -  plasminogen activator, urokinase receptor, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTPRB  -  protein tyrosine phosphatase, receptor type, b, PTPRC  -  protein tyrosine phosphatase, receptor type, c, DOCK8  -  dedicator of cytokinesis 8, WDFY4  -  wdfy family member 4, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0009611	response to wounding	3.86E-4	5.99E-2	2.77	679	14	175	10	[DST  -  dystonin, ADORA3  -  adenosine a3 receptor, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), EXT1  -  exostosin glycosyltransferase 1, EPPK1  -  epiplakin 1, PTK7  -  protein tyrosine kinase 7]
GO:0006955	immune response	3.94E-4	5.96E-2	2.13	679	31	175	17	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, IL1R2  -  interleukin 1 receptor, type ii, EXT1  -  exostosin glycosyltransferase 1, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PXDN  -  peroxidasin homolog (drosophila), VSIG4  -  v-set and immunoglobulin domain containing 4, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, RNF135  -  ring finger protein 135]
GO:0051271	negative regulation of cellular component movement	4.14E-4	6.13E-2	2.40	679	21	175	13	[SRGAP3  -  slit-robo rho gtpase activating protein 3, EPPK1  -  epiplakin 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, DPP4  -  dipeptidyl-peptidase 4, ADORA3  -  adenosine a3 receptor, MEF2C  -  myocyte enhancer factor 2c, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), DPYSL3  -  dihydropyrimidinase-like 3]
GO:0001775	cell activation	4.67E-4	6.76E-2	1.90	679	45	175	22	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-B  -  major histocompatibility complex, class i, b, ABCA13  -  atp-binding cassette, sub-family a (abc1), member 13, KIF13B  -  kinesin family member 13b, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, DPP4  -  dipeptidyl-peptidase 4, PLAUR  -  plasminogen activator, urokinase receptor, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRB  -  protein tyrosine phosphatase, receptor type, b, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, DOCK8  -  dedicator of cytokinesis 8, WDFY4  -  wdfy family member 4, CYFIP1  -  cytoplasmic fmr1 interacting protein 1]
GO:0001818	negative regulation of cytokine production	4.71E-4	6.67E-2	3.10	679	10	175	8	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, VSIG4  -  v-set and immunoglobulin domain containing 4, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, IL1R2  -  interleukin 1 receptor, type ii, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, RNF135  -  ring finger protein 135]
GO:0050777	negative regulation of immune response	4.71E-4	6.53E-2	3.10	679	10	175	8	[HLA-A  -  major histocompatibility complex, class i, a, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, VSIG4  -  v-set and immunoglobulin domain containing 4, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, GPX1  -  glutathione peroxidase 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:2000026	regulation of multicellular organismal development	5.09E-4	6.91E-2	1.44	679	143	175	53	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, ADRB2  -  adrenoceptor beta 2, surface, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, CD38  -  cd38 molecule, DIXDC1  -  dix domain containing 1, HLA-B  -  major histocompatibility complex, class i, b, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, KIF13B  -  kinesin family member 13b, SDC2  -  syndecan 2, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, DISC1  -  disrupted in schizophrenia 1, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, EPHB2  -  eph receptor b2, PLXNA4  -  plexin a4, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, NEGR1  -  neuronal growth regulator 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0030336	negative regulation of cell migration	5.44E-4	7.23E-2	2.45	679	19	175	12	[DPP4  -  dipeptidyl-peptidase 4, KANK1  -  kn motif and ankyrin repeat domains 1, ADORA3  -  adenosine a3 receptor, MEF2C  -  myocyte enhancer factor 2c, VASH1  -  vasohibin 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), DPYSL3  -  dihydropyrimidinase-like 3, EPPK1  -  epiplakin 1]
GO:2000146	negative regulation of cell motility	5.44E-4	7.08E-2	2.45	679	19	175	12	[DPP4  -  dipeptidyl-peptidase 4, KANK1  -  kn motif and ankyrin repeat domains 1, ADORA3  -  adenosine a3 receptor, MEF2C  -  myocyte enhancer factor 2c, VASH1  -  vasohibin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, SRGAP3  -  slit-robo rho gtpase activating protein 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), DPYSL3  -  dihydropyrimidinase-like 3, EPPK1  -  epiplakin 1]
GO:0045597	positive regulation of cell differentiation	5.47E-4	6.99E-2	1.67	679	72	175	31	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, ZBTB16  -  zinc finger and btb domain containing 16, PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, AR  -  androgen receptor, EPHB2  -  eph receptor b2, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, MSR1  -  macrophage scavenger receptor 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, NEGR1  -  neuronal growth regulator 1, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0001525	angiogenesis	7.06E-4	8.84E-2	2.51	679	17	175	11	[NRP2  -  neuropilin 2, VASH1  -  vasohibin 1, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, PTPRB  -  protein tyrosine phosphatase, receptor type, b, GPX1  -  glutathione peroxidase 1, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, NRCAM  -  neuronal cell adhesion molecule]
GO:0007166	cell surface receptor signaling pathway	8.21E-4	1.01E-1	1.46	679	125	175	47	[MUC12  -  mucin 12, cell surface associated, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, DST  -  dystonin, HLA-G  -  major histocompatibility complex, class i, g, IL1R2  -  interleukin 1 receptor, type ii, GPC6  -  glypican 6, ADRB2  -  adrenoceptor beta 2, surface, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PRICKLE1  -  prickle homolog 1 (drosophila), NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, CTNND2  -  catenin (cadherin-associated protein), delta 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), ADCY5  -  adenylate cyclase 5, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), MAOA  -  monoamine oxidase a, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), CYFIP1  -  cytoplasmic fmr1 interacting protein 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, PTK7  -  protein tyrosine kinase 7, HLA-A  -  major histocompatibility complex, class i, a, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, HLA-B  -  major histocompatibility complex, class i, b, DIXDC1  -  dix domain containing 1, CD38  -  cd38 molecule, PRICKLE2  -  prickle homolog 2 (drosophila), TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, EXT1  -  exostosin glycosyltransferase 1, PLXNA4  -  plexin a4, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ADORA3  -  adenosine a3 receptor, SDC2  -  syndecan 2, PLAUR  -  plasminogen activator, urokinase receptor, PRKCB  -  protein kinase c, beta, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, WWOX  -  ww domain containing oxidoreductase, MYO1E  -  myosin ie, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0032944	regulation of mononuclear cell proliferation	9.01E-4	1.09E-1	2.59	679	15	175	10	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, VSIG4  -  v-set and immunoglobulin domain containing 4, BST1  -  bone marrow stromal cell antigen 1, CD38  -  cd38 molecule, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0050670	regulation of lymphocyte proliferation	9.01E-4	1.07E-1	2.59	679	15	175	10	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, VSIG4  -  v-set and immunoglobulin domain containing 4, BST1  -  bone marrow stromal cell antigen 1, CD38  -  cd38 molecule, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0042110	T cell activation	9.01E-4	1.05E-1	2.59	679	15	175	10	[HLA-A  -  major histocompatibility complex, class i, a, DPP4  -  dipeptidyl-peptidase 4, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, DOCK8  -  dedicator of cytokinesis 8, WDFY4  -  wdfy family member 4, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, KIF13B  -  kinesin family member 13b]
GO:0007165	signal transduction	9.39E-4	1.07E-1	1.29	679	231	175	77	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, DST  -  dystonin, HLA-G  -  major histocompatibility complex, class i, g, DOCK4  -  dedicator of cytokinesis 4, ADRB2  -  adrenoceptor beta 2, surface, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, NRP2  -  neuropilin 2, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, BST1  -  bone marrow stromal cell antigen 1, CTNND2  -  catenin (cadherin-associated protein), delta 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), MAOA  -  monoamine oxidase a, DPYSL2  -  dihydropyrimidinase-like 2, DOCK8  -  dedicator of cytokinesis 8, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, APBB1  -  amyloid beta (a4) precursor protein-binding, family b, member 1 (fe65), HLA-A  -  major histocompatibility complex, class i, a, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, HLA-B  -  major histocompatibility complex, class i, b, CD38  -  cd38 molecule, PRICKLE2  -  prickle homolog 2 (drosophila), NR3C2  -  nuclear receptor subfamily 3, group c, member 2, SRGAP3  -  slit-robo rho gtpase activating protein 3, AR  -  androgen receptor, EXT1  -  exostosin glycosyltransferase 1, KIF13B  -  kinesin family member 13b, ARHGAP32  -  rho gtpase activating protein 32, PLAUR  -  plasminogen activator, urokinase receptor, SDC2  -  syndecan 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, RASSF5  -  ras association (ralgds/af-6) domain family member 5, NUAK1  -  nuak family, snf1-like kinase, 1, DISC1  -  disrupted in schizophrenia 1, MYO1E  -  myosin ie, WWOX  -  ww domain containing oxidoreductase, INADL  -  inad-like (drosophila), MUC12  -  mucin 12, cell surface associated, IL1R2  -  interleukin 1 receptor, type ii, GPC6  -  glypican 6, PIK3CG  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, ERG  -  v-ets avian erythroblastosis virus e26 oncogene homolog, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, SPARCL1  -  sparc-like 1 (hevin), PRICKLE1  -  prickle homolog 1 (drosophila), NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), ADCY5  -  adenylate cyclase 5, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ADCY3  -  adenylate cyclase 3, ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, PTK7  -  protein tyrosine kinase 7, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, INPP1  -  inositol polyphosphate-1-phosphatase, DOCK1  -  dedicator of cytokinesis 1, PLXNA4  -  plexin a4, DAPP1  -  dual adaptor of phosphotyrosine and 3-phosphoinositides, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ADORA3  -  adenosine a3 receptor, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK2  -  ankyrin 2, neuronal, ANK3  -  ankyrin 3, node of ranvier (ankyrin g), ARHGEF9  -  cdc42 guanine nucleotide exchange factor (gef) 9]
GO:0042127	regulation of cell proliferation	9.91E-4	1.11E-1	1.54	679	93	175	37	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, GPX1  -  glutathione peroxidase 1, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, EPPK1  -  epiplakin 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, NFIB  -  nuclear factor i/b, DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PBX1  -  pre-b-cell leukemia homeobox 1, NRP2  -  neuropilin 2, BST1  -  bone marrow stromal cell antigen 1, MEF2C  -  myocyte enhancer factor 2c, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ZBTB16  -  zinc finger and btb domain containing 16, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, HLA-A  -  major histocompatibility complex, class i, a, CD38  -  cd38 molecule, AR  -  androgen receptor, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), VSIG4  -  v-set and immunoglobulin domain containing 4, ADORA3  -  adenosine a3 receptor, VASH1  -  vasohibin 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, RASSF5  -  ras association (ralgds/af-6) domain family member 5, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, NUAK1  -  nuak family, snf1-like kinase, 1, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, LAMB1  -  laminin, beta 1]
